| Ident. | Authors (with country if any) | Title |
|---|
| 003954 |
Marianna David [Hongrie] ; Nicholas C. P. Cross [Royaume-Uni] ; Sonja Burgstaller [Autriche] ; Andrew Chase [Royaume-Uni] ; Claire Curtis [Royaume-Uni] ; Raymond Dang [Royaume-Uni] ; Martine Gardembas [France] ; John M. Goldman [Royaume-Uni] ; Francis Grand [Royaume-Uni] ; George Hughes [Royaume-Uni] ; Francoise Huguet [France] ; Louise Lavender [Royaume-Uni] ; Grant A. Mcarthur [Australie] ; Francois X. Mahon [France] ; Giorgio Massimini [Suisse] ; Junia Melo [Royaume-Uni] ; Philippe Rousselot [France] ; Robin J. Russell-Jones [Royaume-Uni] ; John F. Seymour [Australie] ; Graeme Smith [Royaume-Uni] ; Alastair Stark [Royaume-Uni] ; Katherine Waghorn [Royaume-Uni] ; Zariana Nikolova [Suisse] ; Jane F. Apperley [Royaume-Uni] | Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders |
| 003E19 |
Lucy Heady [Royaume-Uni] ; Marivi Fernandez-Serra [France] ; Ricardo L. Mancera [Australie] ; Sian Joyce [Royaume-Uni, Irlande (pays)] ; Ashok R. Venkitaraman [Royaume-Uni] ; Emilio Artacho [Royaume-Uni] ; Chris-Kriton Skylaris [Royaume-Uni] ; Lucio Colombi Ciacchi [Royaume-Uni, Allemagne] ; Mike C. Payne [Royaume-Uni] | Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations |
| 004B52 |
T. V. Nguyen [Australie] ; Martin J. Stebbing [Australie] ; Nadine Clerc [France] ; Mitsu Kawai [Japon] ; John R. Harvey [Australie] ; John B. Furness [Australie] | Evidence for protein kinase involvement in long-term postsynaptic excitation of intrinsic primary afferent neurons in the intestine |
| 005087 |
V. V. Vax [Royaume-Uni] ; R. Bibi [Royaume-Uni] ; S. Diaz-Cano [Royaume-Uni] ; M. Gueorguiev [Royaume-Uni] ; B. Kola [Royaume-Uni] ; N. Borboli [Royaume-Uni] ; B. Bressac-De Paillerets [France] ; G. J. Walker [Australie] ; I. I. Dedov [Russie] ; A. B. Grossman [Royaume-Uni] ; M. Korbonits [Royaume-Uni] | Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours |
| 005089 |
Randy D. Gascoyne [France, Canada, Allemagne, États-Unis, Australie] ; Laurence Lamant ; Jose I. Martin-Subero ; Valia S. Lestou ; Nancy Lee Harris ; Hans-Konrad Müller-Hermelink ; John F. Seymour ; Lynda J. Campbell ; Douglas E. Horsman ; Isabelle Auvigne ; Estelle Espinos ; Reiner Siebert ; Georges Delsol | ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases |
| 005734 |
Anne-Sophie Vercoutter-Edouart [France] ; Jérome Lemoine [France] ; Xuefen Le Bourhis [France] ; Hornez Louis [France] ; Bénoni Boilly [France] ; Victor Nurcombe [Australie] ; Francoise Revillion [France] ; Jean-Philippe Peyrat [France] ; Hubert Hondermarck [France] | Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells |
| 005D91 |
F. Dumortier [Belgique] ; M. Vanhalewyn [Belgique] ; G. Debast [Belgique] ; S. Colombo [Belgique] ; PINGSHENG MA [Belgique] ; J. Winderickx [Belgique] ; P. Van Dijck [Belgique] ; J. M. Thevelein [Belgique] | A specific mutation in Saccharomyces cerevisiae adenylate cyclase, CyrlK1876M, eliminates glucose- and acidification-induced cAMP signalling and delays glucose-induced loss of stress resistance |
| 006615 |
B. Li [États-Unis] ; V. Pacquit [France] ; J.-A. Jiao [États-Unis] ; S. M. G. Duff [États-Unis] ; G. B. Maralihalli [États-Unis] ; G. Sarath [États-Unis] ; S. A. Condon [États-Unis] ; J. Vidal [France] ; R. Chollet [États-Unis] | Structural requirements for phosphorylation of C4-leaf phosphoenolpyruvate carboxylase by its highly regulated protein-serine kinase. A comparative study with synthetic-peptide substrates and mutant target proteins |
| 006D42 |
J. W. Perich [Australie, France] ; F. Meggio ; E. C. Reynolds ; O. Marin ; L. A. Pinna | Role of phosphorlyated aminoacyl residues in generating atypical consensus sequences which are recognized by casein kinase-2 but not by casein kinase-1 |
